Y Mazor - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Y Mazor

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Oral Diseases|August 11, 2015

Effect of Aggregatibacter actinomycetemcomitans from Aggressive Periodontitis patients on Streptococcus mutansA Kozlovsky, A Wolff, M Saminsky, et al.

Journal of Molecular Biology|September 8, 2001

Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodiesH Bach, Y Mazor, S Shaky, et al.

BMC Gastroenterology|January 12, 2024

Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancerE Koifman, M Armoni, Y Gorelik, et al.

Alimentary Pharmacology & Therapeutics|July 22, 2014

Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's diseaseY Mazor, R Almog, U Kopylov, et al.

Alimentary Pharmacology & Therapeutics|February 1, 2012

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBDS Ben-Horin, Y Mazor, H Yanai, et al.

Alimentary Pharmacology & Therapeutics|April 20, 2016

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitisB Ungar, Y Mazor, R Weisshof, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Oral Diseases|August 11, 2015

Effect of Aggregatibacter actinomycetemcomitans from Aggressive Periodontitis patients on Streptococcus mutansA Kozlovsky, A Wolff, M Saminsky, et al.

Journal of Molecular Biology|September 8, 2001

Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodiesH Bach, Y Mazor, S Shaky, et al.

BMC Gastroenterology|January 12, 2024

Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancerE Koifman, M Armoni, Y Gorelik, et al.

Alimentary Pharmacology & Therapeutics|July 22, 2014

Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's diseaseY Mazor, R Almog, U Kopylov, et al.

Alimentary Pharmacology & Therapeutics|February 1, 2012

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBDS Ben-Horin, Y Mazor, H Yanai, et al.

Alimentary Pharmacology & Therapeutics|April 20, 2016

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitisB Ungar, Y Mazor, R Weisshof, et al.

Pageof 2